Global Village
Swiss Business Hub Japan (Embassy of Switzerland in Japan)
| Country: | Japan |
| Global Village: | Delegation of Japan (JPN) |
| Companies: | Swiss Business Hub Japan / Embassy of Switzerland in Japan Astellas Pharma Europe Daiichi Sankyo Eisai Gellycle Co. Genesis Healthcare Hirata Corporation Kissei America Inc Maruho Deutschland GmbH NOF Corporation Otsuka Pharmaceutical Europe Senju Pharmaceutical Co., Ltd. Syncrest Inc Terumo Corporation |
| Roundtable discussion: | Tuesday, 23.04.2024, 12:15-12:45 “Japanese and Swiss Biotech Ecosystem Collaboration” |
Company profile
The Swiss Business Hub Japan (SBHJ) is dedicated to foster business collaboration between Switzerland and Japan. Part of the Swiss Embassy in Tokyo, SBHJ helps Swiss companies do business in Japan and promotes Switzerland as a business location.
Life Science is one of our main focus areas: We are present at the Swiss Biotech Day 2024 with a Japanese delegation consisting of 13 major biotech companies and also organize the Swiss Pavilion at BioJapan 2024 for Swiss companies.
Website: www.s-ge.com/en/company/swiss-business-hub-japan?ct=
Follow us
Astellas Pharma Europe
Daiichi Sankyo
Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas including psychiatric, neurodegenerative and autoimmune diseases. Daiichi Sankyo is also seeking innovative technology for future drug discovery.
Website: https://www.daiichisankyo.com/
Eisai
We are a global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas and we define our corporate mission as “giving first thought to patients and their families, and to increasing the benefits health care provides”. Our work at Eisai prioritises patients and their families through our focus to continually improve the benefits that healthcare can provide. We call this human health care (hhc).
Website: https://www.eisai.eu/who-we-are/
Gellycle Co.
Gellycle Co., Ltd. headquartered in Tokyo, is on a mission to revolutionize medical and industrial fields through its hydrogel technology platform. Spearheaded by the pioneering work of Professor Takamasa Sakai from The University of Tokyo, our hydrogels boast unparalleled biocompatibility and precise physical control, laying the foundation for a new treatment paradigm known as “Gel Medicine.” With a steadfast commitment to addressing Unmet Medical Needs in the 21st century, we aim to enhance the Quality of Life (QOL) for patients globally. Harnessing the world’s foremost Gel Control Technology, Gellycle is poised to make significant strides in improving healthcare outcomes and transforming industries.
Website: https://gellycle.com/home-en
Genesis Healthcare
Genesis Healthcare is Japan’s leading genomic research and testing company, servicing medical institutions, government, corporations, and individuals to benefit from personalized health and precision medicine. GenesisGaia, its genomics platform powered by generative A.I., features the largest commercial genomic database of the Japanese population to accelerate R&D and drug discoveries.
Website: https://www.genesis-healthcare.jp/
Hirata Corporation
Hirata Corporation established a collaboration with public institute of countries rich in diversity and this collaboration provides opportunity to potential user to use Genetic Resources and related Traditional Knowledge (GRTK) in compliance the Nagoya Protocol. The collaboration works like a bridge between source country and user of GRTK and user can obtain the GRTK through the bridge.
Website: https://www.hirata.co.jp/en/
Kissei America Inc
Kissei is an R&D oriented Japanese pharmaceutical company. Our management philosophy is to “Contribute to society through high-quality, innovative pharmaceutical products” and “Serve society through our employees”.
Wesbite: https://www.kissei.co.jp/e_contents/
Maruho Deutschland GmbH
Maruho is a pharmaceutical company which is specializing and the market leader for dermatology in Japan. Our annual sales are approximately 600M EUR mainly for prescription drugs. We would like to expand our business globally especially for Asian market.
Website: https://www.maruho.co.jp/english/
NOF Corporation
NOF CORPORATION (NOF) is a chemical manufacturer that provides new value in a variety of fields, “From the Biosphere to Outer Space”. NOF Group business is classified into three main broad segments: “Functional Chemicals”, “Pharmaceuticals, Medicals and Health”, “Explosives & Propulsion”. NOF is a leading company in supply of materials for Drug Delivery system (DDS), pharmaceutical raw materials and biocompatible materials in life science field. In the DDS field, we are developing new materials in response to the diversification of modalities. NOF is seeking for partners and new technologies in the field of regenerative medicine to develop our materials and to create a new business.
Website: https://www.nof.co.jp/english
Otsuka Pharmaceutical Europe
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy, Otsuka-people creating new products for better health worldwide. Otsuka researches, develops, manufactures, and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.
Website: https://www.otsuka.co.jp/en/
Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. is a research-based pharmaceutical company that develops, manufactures, and commercializes a variety of Rx and OTC products focusing on the field of ophthalmology. Born in Osaka, Japan, Senju Pharmaceutical has manufacturing facilities, R&D center and offices in around the globe. The company is open for collaboration, including but not limited to in- and out-licensing, co-development, research and marketing of innovative products for the treatment of eye diseases.
Syncrest Inc
SynCrest is a leading company that delivers one-stop service for peptide/oligonucleotide-based therapeutics. Our service covers from library synthesis and process development for drug discovery to manufacturing of experimental medicine for clinical studies, support for new product releases, and on-demand commercial manufacturing. We aim to be the best partner of pharmaceutical companies and start-ups and wish to work together for delivering novel drugs to patients worldwide.
Website: https://www.syncrest.com/en/
Terumo Corporation
Terumo Group includes three companies that operate in over 160 countries and regions around the world, providing patients, a variety of medical settings, and the pharmaceutical industry with over 50,000 products and services.
As part of Terumo Medical Care Solutions Company, the Pharmaceutical Solutions Division (PSD) is a leading manufacturer of injection solutions, primary containers, infusion therapy devices, and Contract Development and Manufacturing Organization (CDMO) for parenteral drugs to global pharmaceutical companies.
Website: https://www.terumo.com/
